Ascendis Pharma Unearned Premium on Insurance Contract (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

235.39 +6.74 (+2.95%) USD | NASDAQ | Jan 23, 16:00

240.00 +4.61 (+1.96%) After-Hours: 20:00

View Unearned Premium on Insurance Contract (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

Novo Nordisk A/S	--
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--